Sort
85,873 grants matching “alzheimers”
Testing Tele-Savvy, an On-line Psychoeducation Program for Informal Alzheimer's Caregivers
$785,623Ken W Hepburn · Emory University · R01 · FY2016 · AG
Deciphering molecular mechanisms that underlie brain endothelial cell dysfunction with APOE4
$785,616Leon Maing Tai · University Of Illinois At Chicago · R01 · FY2025 · AG
Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease
$785,596Rajagopal Viswanath Sekhar · Baylor College Of Medicine · R01 · FY2025 · AG
Building an unbiased pooled cohort for the study of lifecourse social and vascular determinants of Alzheimer's Disease and Related Disorders
$785,592Adina Zeki Al Hazzouri · Columbia University Health Sciences · R01 · FY2022 · AG
Alzheimer's Abeta, Tau, Apolipoproteins and Blood-brain barrier
$785,580Berislav V Zlokovic · University Of Southern California · R01 · FY2022 · NS
APOE Genotype Mediated Effects on Alzheimer Disease Risk and Mechanisms
$785,571Lindsay A. Farrer · Boston University Medical Campus · U01 · FY2025 · AG
RCT Targeting Cognition in Early Alzheimer's Disease by Improving Sleep with Trazodone (Rest)
$785,568Barry David Greenberg · Johns Hopkins University · R01 · FY2021 · AG
Regulation of microglia in Alzheimer's Disease by Siglecs and Siglec ligands
$785,544Ronald L Schnaar · Johns Hopkins University · R56 · FY2020 · AG
Affordable Oral Delivery of Human Therapeutic Proteins Bioencapsulated in Plant Cells
$785,508Henry Daniell · University Of Pennsylvania · R01 · FY2021 · HL
Vascular Pathology in Early and Asymptomatic Cerebral Amyloid Angiopathy
$785,505Anand Viswanathan · Massachusetts General Hospital · R01 · FY2025 · AG
Neural indices of online and offline states in human working memory
$785,472Edward Awh · University Of Chicago · R01 · FY2019 · MH
Pharmacokinetic/toxicology & in vivo efficacy of potential AD therapeutic agents
$785,438Sam Khatami · Neuronautics, Inc. · R44 · FY2007 · AG
Testing Olfaction in Primary care to detect Alzheimer's disease and other Dementias (TOPAD)
$785,438Jose A Luchsinger · Columbia University Health Sciences · R01 · FY2018 · AG
ApoE2 and protective molecular signatures in Alzheimer's disease and aging
$785,423Alexander M Kulminski · Duke University · R01 · FY2019 · AG
Impaired activity-dependent protein synthesis in dendrites and pathophysiology in tauopathy
$785,399Tara Tracy · Buck Institute For Research On Aging · R01 · FY2024 · AG
MULTIPLEXED ECHO PLANAR IMAGING FOR NEUROSCIENCES
$785,368David Alan Feinberg · Advanced Mri Technology, Llc · R44 · FY2014 · NS
National Institute on Aging (NIA) Colony
$785,367Jeffrey A Roberts · University Of California At Davis · P51 · FY2020 · OD
California National Primate Research Center (CNPRC) - NIA Supplement
$785,367Prasant Mohapatra · University Of California At Davis · P51 · FY2020 · OD
Identifying the Genetic Etiology of Neuropathology for Alzheimer Disease and Related Dementias
$785,345Gary Wayne Beecham · University Of Miami School Of Medicine · R01 · FY2019 · AG
Biomarker
$785,306Christopher T Whitlow · Wake Forest University Health Sciences · P30 · FY2023 · AG
Biomarker
$785,306Christopher T Whitlow · Wake Forest University Health Sciences · P30 · FY2024 · AG
Biomarker
$785,306Christopher T Whitlow · Wake Forest University Health Sciences · P30 · FY2025 · AG
Biomarker
$785,306Christopher T Whitlow · Wake Forest University Health Sciences · P30 · FY2021 · AG
Biomarker
$785,306Christopher T Whitlow · Wake Forest University Health Sciences · P30 · FY2022 · AG
Ubiquitin Proteasome System and Molecular Signatures of Alzheimer's Disease
$785,292Tauseef R. Butt · Lifesensors, Inc. · R44 · FY2020 · AG